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Of the 5 known subtypes of mAChRs, M2, M3, and M4
have been reported to act as inhibitory presynaptic recep-
tors in the nervous system, in general, and in sympathetic
neurons, in particular. M1 receptors, in contrast, have
rather been viewed as facilitatory presynaptic receptors. In
superior cervical ganglion (SCG) neurons, M1 receptors
are well known to inhibit KCNQ channels. Previously, we
were able to show that non-presynaptic M1 receptors in
SCG neurons enhance noradrenaline release through an
inhibition of KCNQ channels. However, M1 receptors also
mediate an inhibition of voltage-activated Ca2+ channels,
which represents the predominant mechanism of presyn-
aptic inhibition. Hence, presynaptic M1 receptors may
exert inibitory presynaptic modulation. To test this possi-
bility, we performed experiments on rat superior cervical
ganglion neurons. In primary cultures tritium overflow
was assayed to investigate the release of [3H]noradrena-
line, and the perforated patch-clamp technique was
employed to record Ca2+ currents. The muscarinic agonist
oxotremorine M transiently enhanced 3H outflow and
reduced electrically evoked release, once the stimulatory
effect had faded. The stimulatory effect was enhanced by
pertussis toxin and was abolished by blocking M1 recep-
tors, by opening KCNQ channels, and by preventing
action potential propagation. The inhibitory effect, in
contrast, was not altered by preventing action potentials
or by opening KCNQ channels, but was reduced by per-
tussis toxin. The inhibition remaining after pertussis toxin
treatment was abolished by blockage of M1 receptors or
inhibition of phospholipase C. When [3H]noradrenaline
release was triggered independently of voltage-activated
Ca2+ channels, oxotremorine M failed to cause any inhibi-
tion. The inhibition of Ca2+ currents by oxotremorine M
was reduced by pertussis toxin and then abolished by the
blockage of M1 receptors. This demonstrates that M1, in
addition to M2, M3, and M4, receptors mediate presynaptic
inhibition in sympathetic neurons using phospholipase C
to close voltage-activated Ca2+ channels. In addition, our
results contradict the widely accepted concept that all
inhibitory presynaptic receptors restrict transmitter
release through a direct inhibition of Ca2+ channels via G
protein βγ subunits and offer an alternative mechanism.
Acknowledgements
This study was supported by grants P17611 and P19710 from the Austrian 
Science Fund (FWF).
from 14th Scientific Symposium of the Austrian Pharmacological Society (APHAR)
Innsbruck, Austria. 21–22 November 2008
Published: 5 November 2008
BMC Pharmacology 2008, 8(Suppl 1):A42 doi:10.1186/1471-2210-8-S1-A42
<supplement> <title> <p>14<sup>th </sup>Scientific Symposium of the Austrian Pharmacological Society (APHAR)</p> </title> <editor>Andrea Laslop and Thomas Griesbacher</editor> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1471-2210-8-S1-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1471-2210-8-S1-info.pdf</url> </supplement>
This abstract is available from: http://www.biomedcentral.com/1471-2210/8/S1/A42
© 2008 Kubista et al; licensee BioMed Central Ltd. 